Clinical Trial

Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status

Completed
View on ClinicalTrials.gov →
Summary
Chronic inflammation underlies the bidirectional relationship between diabetes and periodontitis, a process that may be further exacerbated in the presence of diabetic nephropathy. While the roles of inflammatory cytokines such as TNF-α and IL-10 in both periodontal tissue destruction and diabetes-related microvascular complications remain unclear, NGAL is recognized as a biomarker for diabetic nephropathy but its association with periodontal disease is not well established. This study aimed to comparatively evaluate salivary and serum levels of NGAL, TNF-α, and IL-10 according to different periodontal conditions in individuals with newly diagnosed diabetes and those with diabetic nephropathy.
Trial Details
NCT Number NCT07498894
Lead Sponsor Pamukkale University
Conditions Diabetic Nephropathy Type 2, Type 2 Diabetes, Periodontitis, Gingivitis, Periodontal Health
Enrollment 126 participants
Start Date 2024-06-10
Primary Completion 2025-12-12 (estimated)
Study Completion 2025-12-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-27